307 related articles for article (PubMed ID: 37812432)
41. Perforant path synaptic loss correlates with cognitive impairment and Alzheimer's disease in the oldest-old.
Robinson JL; Molina-Porcel L; Corrada MM; Raible K; Lee EB; Lee VM; Kawas CH; Trojanowski JQ
Brain; 2014 Sep; 137(Pt 9):2578-87. PubMed ID: 25012223
[TBL] [Abstract][Full Text] [Related]
42. Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.
Quiroz YT; Sperling RA; Norton DJ; Baena A; Arboleda-Velasquez JF; Cosio D; Schultz A; Lapoint M; Guzman-Velez E; Miller JB; Kim LA; Chen K; Tariot PN; Lopera F; Reiman EM; Johnson KA
JAMA Neurol; 2018 May; 75(5):548-556. PubMed ID: 29435558
[TBL] [Abstract][Full Text] [Related]
43. The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system.
Tai HC; Serrano-Pozo A; Hashimoto T; Frosch MP; Spires-Jones TL; Hyman BT
Am J Pathol; 2012 Oct; 181(4):1426-35. PubMed ID: 22867711
[TBL] [Abstract][Full Text] [Related]
44. Application of deep learning to understand resilience to Alzheimer's disease pathology.
Lee CS; Latimer CS; Henriksen JC; Blazes M; Larson EB; Crane PK; Keene CD; Lee AY
Brain Pathol; 2021 Nov; 31(6):e12974. PubMed ID: 34009663
[TBL] [Abstract][Full Text] [Related]
45. Alzheimer's-related changes in non-demented essential tremor patients vs. controls: links between tau and tremor?
Pan JJ; Lee M; Honig LS; Vonsattel JP; Faust PL; Louis ED
Parkinsonism Relat Disord; 2014 Jun; 20(6):655-8. PubMed ID: 24679899
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
[TBL] [Abstract][Full Text] [Related]
47. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.
Chen MK; Mecca AP; Naganawa M; Finnema SJ; Toyonaga T; Lin SF; Najafzadeh S; Ropchan J; Lu Y; McDonald JW; Michalak HR; Nabulsi NB; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
JAMA Neurol; 2018 Oct; 75(10):1215-1224. PubMed ID: 30014145
[TBL] [Abstract][Full Text] [Related]
48. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers.
Kester MI; Goos JD; Teunissen CE; Benedictus MR; Bouwman FH; Wattjes MP; Barkhof F; Scheltens P; van der Flier WM
JAMA Neurol; 2014 Jul; 71(7):855-62. PubMed ID: 24818585
[TBL] [Abstract][Full Text] [Related]
49. Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer's Disease.
Buchanan H; Mackay M; Palmer K; Tothová K; Katsur M; Platt B; Koss DJ
Mol Neurobiol; 2020 Aug; 57(8):3258-3272. PubMed ID: 32514860
[TBL] [Abstract][Full Text] [Related]
50. Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults.
Karanth S; Nelson PT; Katsumata Y; Kryscio RJ; Schmitt FA; Fardo DW; Cykowski MD; Jicha GA; Van Eldik LJ; Abner EL
JAMA Neurol; 2020 Oct; 77(10):1299-1307. PubMed ID: 32568358
[TBL] [Abstract][Full Text] [Related]
51. Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging Brains.
Zeppenfeld DM; Simon M; Haswell JD; D'Abreo D; Murchison C; Quinn JF; Grafe MR; Woltjer RL; Kaye J; Iliff JJ
JAMA Neurol; 2017 Jan; 74(1):91-99. PubMed ID: 27893874
[TBL] [Abstract][Full Text] [Related]
52. Cofilin rods and aggregates concur with tau pathology and the development of Alzheimer's disease.
Rahman T; Davies DS; Tannenberg RK; Fok S; Shepherd C; Dodd PR; Cullen KM; Goldsbury C
J Alzheimers Dis; 2014; 42(4):1443-60. PubMed ID: 25024349
[TBL] [Abstract][Full Text] [Related]
53. Absence of amyloid β oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer's disease neuropathology.
Bjorklund NL; Reese LC; Sadagoparamanujam VM; Ghirardi V; Woltjer RL; Taglialatela G
Mol Neurodegener; 2012 May; 7():23. PubMed ID: 22640423
[TBL] [Abstract][Full Text] [Related]
54. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
[TBL] [Abstract][Full Text] [Related]
55. Microglia-Synapse Pathways: Promising Therapeutic Strategy for Alzheimer's Disease.
Xie J; Wang H; Lin T; Bi B
Biomed Res Int; 2017; 2017():2986460. PubMed ID: 28473983
[TBL] [Abstract][Full Text] [Related]
56. Dysfunctional microglia and tau pathology in Alzheimer's disease.
Ayyubova G
Rev Neurosci; 2023 Jun; 34(4):443-458. PubMed ID: 36302379
[TBL] [Abstract][Full Text] [Related]
57. Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β.
Therriault J; Benedet AL; Pascoal TA; Mathotaarachchi S; Chamoun M; Savard M; Thomas E; Kang MS; Lussier F; Tissot C; Parsons M; Qureshi MNI; Vitali P; Massarweh G; Soucy JP; Rej S; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P
JAMA Neurol; 2020 Apr; 77(4):470-479. PubMed ID: 31860000
[TBL] [Abstract][Full Text] [Related]
58. Translocator protein in late stage Alzheimer's disease and Dementia with Lewy bodies brains.
Xu J; Sun J; Perrin RJ; Mach RH; Bales KR; Morris JC; Benzinger TLS; Holtzman DM
Ann Clin Transl Neurol; 2019 Aug; 6(8):1423-1434. PubMed ID: 31402620
[TBL] [Abstract][Full Text] [Related]
59. Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease.
Dean DC; Hurley SA; Kecskemeti SR; O'Grady JP; Canda C; Davenport-Sis NJ; Carlsson CM; Zetterberg H; Blennow K; Asthana S; Sager MA; Johnson SC; Alexander AL; Bendlin BB
JAMA Neurol; 2017 Jan; 74(1):41-49. PubMed ID: 27842175
[TBL] [Abstract][Full Text] [Related]
60. Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density.
Samuel W; Alford M; Hofstetter CR; Hansen L
J Neuropathol Exp Neurol; 1997 May; 56(5):499-508. PubMed ID: 9143263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
